Investors Home Financials SEC Filings
SEC Filings

SEC Filings

Select the filing type and date range you wish to view from the drop-down menus below.

NASDAQBLFS
YearTrailing 12-MonthsCalendar Year 2026Calendar Year 2025Calendar Year 2024Calendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011Calendar Year 2010Calendar Year 2009Calendar Year 2008Calendar Year 2007Calendar Year 2006Calendar Year 2005Calendar Year 2004Calendar Year 2003Calendar Year 2002Calendar Year 2001Calendar Year 2000Calendar Year 1999Calendar Year 1998Calendar Year 1997Calendar Year 1996Calendar Year 1995
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Proxy & Information StatementsOther
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesDec 17, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
4Statement of changes in beneficial ownership of securitiesDec 17, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
4Statement of changes in beneficial ownership of securitiesDec 17, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
4Statement of changes in beneficial ownership of securitiesDec 17, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
4Statement of changes in beneficial ownership of securitiesDec 17, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
4Statement of changes in beneficial ownership of securitiesDec 17, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
144Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stockDec 15, 2025Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in HTML.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in DOC file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in PDF file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in XLS file.
4Statement of changes in beneficial ownership of securitiesDec 05, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
144Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stockDec 04, 2025Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in HTML.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in DOC file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in PDF file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in XLS file.
4Statement of changes in beneficial ownership of securitiesNov 28, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
4Statement of changes in beneficial ownership of securitiesNov 28, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
4Statement of changes in beneficial ownership of securitiesNov 28, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
4Statement of changes in beneficial ownership of securitiesNov 28, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
4Statement of changes in beneficial ownership of securitiesNov 28, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
4Statement of changes in beneficial ownership of securitiesNov 28, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
4Statement of changes in beneficial ownership of securitiesNov 28, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
4Statement of changes in beneficial ownership of securitiesNov 21, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
8-KReport of unscheduled material events or corporate eventNov 17, 2025Open Report of unscheduled material events or corporate event in HTML.Open Report of unscheduled material events or corporate event in DOC file.Open Report of unscheduled material events or corporate event in PDF file.Open Report of unscheduled material events or corporate event in XLS file.Open Report of unscheduled material events or corporate event in XBLR Viewer.Open Report of unscheduled material events or corporate event in XBLR file.
4Statement of changes in beneficial ownership of securitiesNov 13, 2025Open Statement of changes in beneficial ownership of securities in HTML.Open Statement of changes in beneficial ownership of securities in DOC file.Open Statement of changes in beneficial ownership of securities in PDF file.Open Statement of changes in beneficial ownership of securities in XLS file.
144Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stockNov 13, 2025Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in HTML.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in DOC file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in PDF file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in XLS file.
144Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stockNov 12, 2025Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in HTML.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in DOC file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in PDF file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in XLS file.
144Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stockNov 12, 2025Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in HTML.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in DOC file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in PDF file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in XLS file.
144Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stockNov 12, 2025Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in HTML.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in DOC file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in PDF file.Open Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock in XLS file.
8-KReport of unscheduled material events or corporate eventNov 06, 2025Open Report of unscheduled material events or corporate event in HTML.Open Report of unscheduled material events or corporate event in DOC file.Open Report of unscheduled material events or corporate event in PDF file.Open Report of unscheduled material events or corporate event in XLS file.Open Report of unscheduled material events or corporate event in XBLR Viewer.Open Report of unscheduled material events or corporate event in XBLR file.
10-QQuarterly report which provides a continuing view of a company's financial positionNov 06, 2025Open Quarterly report which provides a continuing view of a company's financial position in HTML.Open Quarterly report which provides a continuing view of a company's financial position in DOC file.Open Quarterly report which provides a continuing view of a company's financial position in PDF file.Open Quarterly report which provides a continuing view of a company's financial position in XLS file.Open Quarterly report which provides a continuing view of a company's financial position in XBLR Viewer.Open Quarterly report which provides a continuing view of a company's financial position in XBLR file.
1-25      26-50      51-75      76-100      101-125      126-150      151-152

We believe the promise of cell and gene therapies starts with the integrity of a single cell

Free
Sample
Request
Free
Sample
Request

Advancing the future of cell and gene therapy

The human body can heal itself. Cell and gene therapies are designed to augment the patient’s ability to fight disease but only if the living cells behind those therapies remain viable and functional throughout the production processes. At BioLife Solutions, our mission is to protect the integrity of cells and provide trusted tools, services, and expertise that can enable our customers to advance the development and delivery of cell and gene therapies. We believe the future of cell and gene therapies hinges on the integrity of every single cell and we are here to protect that promise.

We understand the technical demands of bioprocessing in this field, and our advanced biopreservation expertise, cell culture optimization products, innovative storage systems, and closed-system manufacturing solutions are designed to enhance process efficiency, maintain cellular viability, and ensure reproducibility at every stage. Whether scaling up from R&D, navigating clinical trials or optimizing cryopreservation protocols for commercial production, we provide the tools and experience to streamline your workflow and safeguard your therapies.

Work with experts who understand your biopreservation challenges

Connect with
our experts

Ask the Scientists
Ask the Scientists
Notch-Bottom-25px

Explore our
solutions

General Inquiries
General Inquiries
Notch-Bottom-25px
Notch-Right-25px
Notch-Bottom-25px

Collaborative and comprehensive CDMO support

At BioLife Solutions, we partner with leading contract development and manufacturing organizations (CDMOs) to enhance their biopreservation and cell processing capabilities. By providing advanced tools, regulatory support, and process optimization strategies, we empower CDMOs to better serve therapy developers, ensuring quality, consistency, and scalability in cell therapy manufacturing.

Learn more
Learn more

Regulatory
readiness

Navigating the complex regulatory landscape of cell and gene therapy requires a proactive approach. BioLife Solutions offers experienced regulatory support to help prepare your biopreservation and cell processing methods to meet global standards. From IND and BLA submissions to compliance with GMP, FDA, and EMA guidelines, our solutions help streamline approval pathways.

Learn more
Learn more
Notch-Left-25px
Notch-Bottom-25px

STORE

CellSeal®
CryoCase

Alleviate CGT container challenges like fracture risk, bag burping or high rates of particulates

Shop now
Shop now
Notch-Right-25px
Notch-Bottom-25px

Data-driven
decision making

Stay ahead with our comprehensive Evidence Library, a curated collection of scientific publications, white papers, and case studies demonstrating the efficacy of BioLife Solutions’ technologies. Access peer-reviewed research, real-world application data, and expert insights to support your bioprocessing and regulatory strategies.

Evidence Library
Evidence Library

Insights

News
APD_240715_BioLifeSolutions_Edit069-scaled
Insights-Notch
May 21, 2025

Designing the Ideal Cryostorage Container for CGT

Read more
News
Two female scientists in lab coats reviewing data on a tablet in a laboratory setting.
Insights-Notch
April 18, 2025

The Cell Summit ’25: A Must-Attend Event for Innovators in Cell & Gene Therapy

Read more
Cryopreservation
Patient undergoing apheresis procedure with blood drawn through tubing connected to a machine that separates blood components, while a healthcare worker in protective gear monitors the process.
Insights-Notch
March 27, 2025

Optimizing Biopreservation Strategies for Apheresis-Derived Cells in Immunotherapeutic Applications

Read more
News
Early Preparation for IND and BLA Submissions. Illustration of the phases of vaccine clinical trials, showing a progression from preclinical research to Phase 1, Phase 2, Phase 3, and regulatory approval, with icons representing laboratory testing, small and large groups of participants, and final distribution.
Insights-Notch
February 19, 2025

How to prepare early for regulatory submissions from IND to BLA

Read more
View more
View more

Preserve, protect and expand cell performance

Mastering
Biopreservation

Discover
Discover

Ensure Regulatory Submission Readiness

Discover
Discover

Automate & Close
CGT Processes

Discover
Discover

Protect & Expand
Cell Performance

Discover
Discover